Top

Published in:

01-12-2013 | HOT TOPIC

Heart Failure in Children in Tropical Regions

Authors: Manojkumar Rohit, Ankur Gupta, K. K. Talwar

Published in: Current Heart Failure Reports | Issue 4/2013

Abstract

With the ever increasing younger population in tropical countries, the number of children with heart failure is increasing. However, the etiology of heart failure in this region varies considerably from that in the temperate region, with infectious causes leading the list. In this review, we have summarized the important causes of heart failure seen in the pediatric population in tropical regions.

Hsu DT, Pearson GD. Heart failure in children part I: history, etiology, and pathophysiology. Circ Heart Fail. 2009;2:63–70.PubMedCrossRef

Sommers C, Nagel B, Neudorf U, Schmaltz AA. Congestive heart failure in childhood. An epidemiologic study. Herz. 2005;30:652–62.PubMedCrossRef

Massin MM, Astadicko I, Dessy H. Epidemiology of heart failure in a tertiary pediatriccenter. Clin Cardiol. 2008;31:388–91.PubMedCrossRef

Andrews RE, Fenton MJ, Ridout DA, Burch M. New onset heart failure due to heart muscle disease in childhood: a prospective study in the United Kingdom and Ireland. Circulation. 2008;117:79–84.PubMedCrossRef

Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647–55.PubMedCrossRef

Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, et al. Incidence, causes and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296:1867–76.PubMedCrossRef

Ross RD, Daniels SR, Schwartz DC, Hannon DW, Shukla R, Kaplan S. Plasma levels of norepinephrine in infants and children with congestive heart failure. Am J Cardiol. 1987;59:911–4.PubMedCrossRef

Ross RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Pediatr Cardiol. 1992;13:72–5.PubMedCrossRef

•• Ross RD. The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision. Pediatr Cardiol. 2012;33:1295–300. An excellent review discussing various classifications and scoring systems for heart failure in children and proposing a new age-based modification of Ross classification.PubMedCrossRef

10.

Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. J Pediatr. 2001;138:644–8.PubMedCrossRef

11.

Tissières P, Aggoun Y, Da Cruz E, Sierra J, Mensi N, Kalagos A, et al. Comparison of classifications for heart failure in children undergoing valvular surgery. J Pediatr. 2006;149:210–5.PubMedCrossRef

12.

Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639–46.PubMedCrossRef

13.

Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics. 1998;101:369–76.PubMedCrossRef

14.

Griffin ML, Hernandez A, Martin TC, Goldring D, Bolman RM, Spray TL, et al. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol. 1988;11:139–44.PubMedCrossRef

15.

Kumar K, Thatai D, Saxena A, Srinivas V, Juneja R, Kothari SS, et al. Pediatric dilated cardiomyopathy: prognosis in a developing nation is comparable to developed nations. J Am Coll Cardiol. 1996;27:S187.CrossRef

16.

Taliercio CP, Seward JB, Driscoll DJ, Fisher LD, Gersh BJ, Tajik AJ. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol. 1985;6:1126–31.PubMedCrossRef

17.

Chen SC, Nouri S, Balfour I, Jureidini S, Appleton RS. Clinical profile of conjestive cardiomyopathy in children. J Am Coll Cardiol. 1990;15:189–93.PubMedCrossRef

18.

Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE. Dilated cardiomyopathy in children: determinants of outcome. Br Heart J. 1994;72:246–50.PubMedCrossRef

19.

Pophal SG, Sigfusson G, Booth KL, Bacanu S-A. Complication of endomyocardial biopsies in children. J Am Coll Cardiol. 1999;34:2105–10.PubMedCrossRef

20.

Talwar KK, Somnath HS, Chopra P, Shrivastava S, Saxena A, Narula J. Endomyocardial biopsy in children.[abstract]. Indian Heart J. 1991;43:321.

21.

Talwar KK, Varma S, Chopra P, Wasir HS. Endomyocardial biopsy—technical aspects experience and current status. An Indian perspective. Int J Cardiol. 1994;43:327–34.PubMedCrossRef

22.

Aggarwal BL. Rheumatic heart disease unabated in developing countries. Lancet. 1981;2:910–1.CrossRef

23.

Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser. 2004;923:1–122.

24.

Markowitz M. Evolution and critique of changes in the Jones criteria for the diagnosis of rheumatic fever. N Z Med J. 1988;101:392–4.PubMed

25.

Narula J, Reddy KS, Khaw BA. Can antimyosinscintigraphy supplement the Jones Criteria in the diagnosis of active rheumatic carditis? In: Khaw BA, Narula J, Strauss HW, editors. Monoclonal antibodies in cardiovascular diseases. Philadelphia: Lea & Febiger; 1994.

26.

Narula J, Chopra P, Talwar KK, Vasan RS, Reddy KS, Tandon R, et al. Endomyocardial biopsies in acute rheumatic fever. Circulation. 1993;88:2198–205.PubMedCrossRef

27.

Roy SB, Bhatia ML, Lazaro EJ, Ramalingaswami V. Juvenile mitral stenosis in India. Lancet. 1963;2:1193–6.PubMedCrossRef

28.

Gamra H, Betbout F, Hamda KB, Addad F, Maatouk F, Dridi Z, et al. Balloon mitral commissurotomy in juvenile rheumatic mitral stenosis: a ten-year clinical and echocardiographic actuarial results. Eur Heart J. 2003;24:1349–56.PubMedCrossRef

29.

Kothari SS, Ramakrishnan S, Kumar CK, Juneja R, Yadav R. Intermediate-term results of percutaneoustransvenous mitral commissurotomy in children less than 12 years of age. Catheter Cardiovasc Interv. 2005;64:487–90.PubMedCrossRef

30.

Nishimura RA. Constrictive pericarditis in the modern era: a diagnostic dilemma. Heart. 2001;86:619–23.PubMedCrossRef

31.

Bashi VV, John S, Ravikumar E, Jairaj PS, Shyamsunder K, Krishnaswami S. Early and late results of pericardiectomy in 118 cases of constrictive pericarditis. Thorax. 1988;43:637–41.PubMedCrossRef

32.

Anand SS, Saini VK, Wahi PL. Constrictive pericarditis. Dis Chest. 1965;47:291–5.PubMedCrossRef

33.

Bhayana JN, Prusty S, Singhal VS, Gupta MP, Sharma SR, Padmavati S. Surgical treatment of constrictive pericarditis. Indian Heart J. 1971;23:205–11.PubMed

34.

Hageman JH, D’esopo ND, Glenn WW. Tuberculosis of the pericardium. A long-term analysis of forty-four proved cases. N Engl J Med. 1964;270:327–32.PubMedCrossRef

35.

Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF. Cytokine production in patients with tuberculous pericarditis. Int J Tuberc Lung Dis. 2002;6:439–46.PubMed

36.

Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation. 1989;80:299–305.PubMedCrossRef

37.

Spodick D. Low atrial natriuretic factor levels and absent pulmonary edema in pericardial compression of the heart. Am J Cardiol. 1989;63:1271–2.PubMedCrossRef

38.

Sivasankaran S. Restrictive cardiomyopathy in India: the story of a vanishing mystery. Heart. 2009;95:9–14.PubMedCrossRef

39.

Mocumbi AO, Yacoub S, Yacoub MH. Neglected tropicalcardiomyopathies: II. Endomyocardial fibrosis: myocardial disease. Heart. 2008;94:384–90.PubMedCrossRef

40.

Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH. A populationstudy of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med. 2008;359:43–9.PubMedCrossRef

41.

Hutt MS. Epidemiology aspects of endomyocardial fibrosis. Postgrad Med J. 1983;59:142–6.PubMedCrossRef

42.

Ball JD, Williams AW, Davies JN. Endomyocardial fibrosis. Lancet. 1954;266:1049–54.PubMedCrossRef

43.

Roberts WC, Liegler DG, Carbone PP. Endomyocardial disease and eosinophilia: a clinical and pathologic spectrum. Am J Med. 1969;46:28–42.PubMedCrossRef

44.

Sandhyamani S. Vasculopathic and cardiomyopathic changes induced by low-protein high-carbohydrate tapioca based diet in bonnet monkey. Vasculopathic and cardiomyopathic changes in induced malnutrition. Am J Cardiovasc Pathol. 1992;4:41–50.PubMed

45.

Smith B, Chenery SRN, Cook JM, Styles MT, Tiberindwa JV, Hampton C, et al. Geochemical and environmental factors controlling exposure to cerium and magnesium in Uganda. J Geochem Explor. 1998;65:1–15.CrossRef

46.

McManus BM, Bren GB, Robertson EA. Haemodynamic cardiac constriction without anatomic myocardial restriction or pericardial constriction. Am Heart J. 1981;102:134–6.PubMedCrossRef

47.

Ammash NM, Seward JB, Bailey KR, Edwards WD, Tajik AJ. Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation. 2000;101:2490–6.PubMedCrossRef

48.

Seth S, Thatai D, Sharma S, Chopra P, Talwar KK. Clinico-pathological evaluation of restrictive cardiomyopathy [emdomyocardial fibrosis and idiopathic restrictive cardiomyopathy] in India. Eur J Heart Fail. 2004;6:723–9.PubMedCrossRef

49.

Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical course of endomyocardial fibrosis. Br Heart J. 1989;62:450–4.PubMedCrossRef

50.

Nath I, Reddy KS, Dinshaw KA, Bhisey AN, Krishnaswami K, Bhan MK, et al. Country profile: India. Lancet. 1998;351:1265–75.PubMedCrossRef

51.

Ramankutty V, Soman CR, Vijayakumar K. Pattern of helminthic infestation in primary school children of Thiruvananthapuram district. Kerala research programme on local development. Centre for development studies, Thiruvanathapuram. p. 1–16. Discussion paper No. 19: 2000. Available from: http://www.cds.ac.in/krpcds/publication/ramankutty.htm, accessed on September 5, 2012.

52.

Sharma M, Kothari SS, Shrivastava S. Hypereosinophilic syndrome in a young child presenting as a right ventricle mural thrombus. Indian Heart J. 1993;45:287–8.PubMed

53.

• Narula N, Mahajan R, Rohit M. Loeffler’s syndrome. Pediatr Cardiol. 2010;31:931–2. A case report of a 9 year old boy presenting with typical finding of Loeffler’s syndrome, reported from North India.PubMedCrossRef

54.

Ladhani S, Tulloh R, Anderson D. Takayasu disease masquerading as interruption aorta in a 2 years old child. Cardiol Young. 2001;11:244–6.PubMedCrossRef

55.

Hong CY, Yung YS, Choi JY, Sul JH, Lee KS, Cha SH, et al. Takayasu arteritis in Korean children clinical report of seventy cases. Heart Vessels Suppl. 1992;7:91–6.PubMedCrossRef

56.

Hahn D, Thomson PD, Kala U, Beale PG, Levin SE. A review of Takayasu arteritis in children in Gauteng, South Africa. Pediatr Nephrol. 1998;12:668–75.PubMedCrossRef

57.

Jain S, Sharma N, Singh S, Bali HK, Kumar L, Sharma BK. Takayasu arteritis in children and young Indians. Int J Cardiol. 2000;75:53–7.CrossRef

58.

Talwar KK, Kumar K, Chopra P, Sharma S, Shrivastava S, Wasir HS, et al. Cardiac involvement in nonspecific aortoarteritis [Takayasu’s arteritis]. Am Heart J. 1991;122:1666–70.PubMedCrossRef

59.

Ramamurthy S, Talwar KK, Sharma S. Extensive dissection requiring multiple stents following balloon angioplasty for non-specific aorto-arteritis. J Invasive Cardiol. 2003;15:49–51.PubMed

60.

Morale E, Pineda C, Martinez-Lavin M. Takayasu arteritis in children. J Rheumatol. 1991;18:1081–4.

61.

Carvajal K, Moreno-Sánchez R. Heart metabolic disturbances in cardiovascular diseases. Arch Med Res. 2003;34:89–99.PubMedCrossRef

62.

Abdullah M, Bigras JL, McCrindle BW. Dilated cardiomyopathy as a first sign of nutritional vitamin D deficiency rickets in infancy. Can J Cardiol. 1999;15:699.PubMed

63.

Brunvand L, Haga P, Tangsrud S, Haug E. Congestive heart failure caused by vitamin D deficiency? Acta Paediatr. 1995;84:106–8.PubMedCrossRef

64.

Carlton-Conway D, Tulloh R, Wood L, Kanabar D. Vitamin D deficiency and cardiac failure in infancy. J R Soc Med. 2004;97:238–9.PubMedCrossRef

65.

Olgun H, Ceviz N, Ozkan B. A case of dilated cardiomyopathy due to nutritional vitamin D deficiency rickets. Turk J Pediatr. 2003;45:152–4.PubMed

66.

• Verma S, Khadwal A, Chopra K, Rohit M, Singhi S. Hypocalcemia nutritional rickets: a curable cause of dilated cardiomyopathy. J Trop Pediatr. 2011;57:126–8. A case report describing a 15 months old child with diagnosis of dilated cardiomyopathy, etiology being hypocalcemic nutritional rickets.PubMedCrossRef

67.

Dursun A, Aliefendioğlu D, Ozkan B, Coşkun T. Carnitinuria in rickets due to vitamin D deficiency. Turk J Pediatr. 2000;42:278.PubMed

68.

Beuckelmann D, Näbauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85:1046–55.PubMedCrossRef

69.

Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003;41:105–12.PubMedCrossRef

70.

Packer DL, Brady GH, Worley SJ, Smith MS, Cobb FR, Coleman RE, et al. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol. 1986;57:563–70.PubMedCrossRef

71.

Cruz FE, Cheriex EC, Smeets JL, Atiè J, Peres AK, Penn OC, et al. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol. 1990;16:739–44.PubMedCrossRef

72.

Fyfe DA, Gillete PC, Crawford Jr FA, Kline CH. Resolution of dilated cardiomyopathy after surgical ablation of ventricular tachycardia in a child. J Am Coll Cardiol. 1987;9:231–4.PubMedCrossRef

73.

Spinale FG, Zellner JL, Tomita M, Crawford FA, Zile MR. Relation between ventricular and myocyteremodeling with the development and regression of supraventricular tachycardiainduced cardiomyopathy. Circ Res. 1991;69:1058–67.PubMedCrossRef

74.

Zellner JL, Spinale FG, Eble DM, Hewett KW, Crawford Jr FA. Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Circ Res. 1991;69:590–600.PubMedCrossRef

75.

Burchell SA, Spinale FG, Crawford FA, Tanaka R, Zile MR. Effects of chronic tachycardia-induced cardiomyopathy on the betaadrenergic receptor system. J Thorac Cardiovasc Surg. 1992;104:1006–12.PubMed

76.

Tanaka R, Fulbright B, Mukherjee R, Burchell SA, Crawford FA, Zile MR, et al. The cellular basis for the blunted response to betaadrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. J Mol Cell Cardiol. 1993;25:1215–33.PubMedCrossRef

77.

Spinale FG, Tanaka R, Crawford FA, Zile MR. Changes in myocardial blood flow during development of and recovery from tachycardiainduced cardiomyopathy. Circulation. 1992;85:717–29.PubMedCrossRef

78.

De Giovanni JV, Dindar A, Griffith MJ, Edgar RA, Silone ED, Stumper O, et al. Recovery pattern of left ventricular dysfunction following radiofrequency ablation of incessant supraventricular tachycardia in infants and children. Heart. 1998;79:588–92.PubMed

79.

Fishberger SB, Colan SD, Saul JP, Mayer Jr JE, Walsh EP. Myocardial mechanics before and after ablation of chronic tachycardia. Pacing Clin Electrophysiol. 1996;19:42–9.PubMedCrossRef

80.

Juneja R, Shah S, Naik N, Kothari SS, Saxena A, Talwar KK. Management of cardiomyopathy resulting from incessant supraventricular tachycardia in infants and children. Indian Heart J. 2002;54:176–80.PubMed

81.

Statement on sarcoidosis. Joint statement of the American thoracic society [ATS], the European respiratory society [ERS] and the world association of sarcoidosis and other granulomatous disorders [WASOD] adopted by the ATS board of directors and by the ERS executive committee, February 1999. Am J RespirCrit Care Med. 1999;160:736–55.

82.

Kumar R, Goel N, Gaur SN. Sarcoidosis in north Indian population: a retrospective study. Indian J Chest Dis Allied Sci. 2012;54:99–104.PubMed

83.

•• Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Sarcoidosis and tuberculosis: the same disease with different manifestations or similar manifestations of different disorders. Curr Opin Pulm Med. 2012;18:506–16. A review debating the relationship between sarcoidosis and tuberculosis and finding a common link between the two.PubMedCrossRef

84.

Patishall EN, Kendig EL. Sarcoidosis in children. Pediatr Pulmonol. 1996;22:195–203.CrossRef

85.

Hafner R, Vogel R. Sarcoidosis of early onset. A challenge for the pediatric rheumatologist. Clin Exp Rheumatol. 1993;11:685–91.PubMed

86.

Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest. 1993;103:253–8.PubMedCrossRef

87.

Rose AG. Cardiac tuberculosis: a study of 19 patients. Arch Pathol Lab Med. 1987;111:422–6.PubMed

88.

Kinare SG. Interesting facets of cardiovascular tuberculosis. Indian J Surg. 1975;37:145–51.

89.

Daxini BV, Mandke JV, Sharma S. Echocardiographic recognision of tubercular submitral left ventricular aneurysm extending into left atrium. Am Heart J. 1990;119:970–2.PubMedCrossRef

Title: Heart Failure in Children in Tropical Regions
Authors: Manojkumar Rohit
Ankur Gupta
K. K. Talwar
Publication date: 01-12-2013
Publisher: Springer US
Published in: Current Heart Failure Reports / Issue 4/2013
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI: https://doi.org/10.1007/s11897-013-0158-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2013

Prognostic Factors in Patients Hospitalized for Heart Failure

Critical Appraisal of Costly Therapy Modalities for Heart Failure in a Developing Country

The Emerging Epidemic of Heart Failure with Preserved Ejection Fraction

Changes in Renal Function in Congestive Heart Failure

Revascularization in Heart Failure in the Post-STICH Era

Cardiac Metaiodobenzylguanidine Imaging and Heart Failure

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials